Deepa Jewellers Ltd successfully raised Rs 138 crore from anchor investors this past Monday. Their initial public offering opens for subscription on September 1 and includes both fresh share issuance and an offer-for-sale. The proceeds are intended for enhancing working capital and supporting various corporate objectives. The shares are set to be listed on the BSE and NSE beginning September 8.
Blackstone-backed Epsilon Bidco plans to sell its 26.4% stake in packaging firm EPL Ltd through a block deal valued at approximately Rs 1,985 crore. The shares are offered at Rs 235 each, marking a discount to the current market price.
NCDEX launched RAINCHNNAI, a rainfall-based weather futures contract, enabling participants to hedge Northeast Monsoon risks. Covering September-December, the cash-settled contract uses IMD rainfall data and complements RAINMUMBAI, expanding exchange-traded tools for managing weather-linked financial exposure.
The National Stock Exchange’s anticipated IPO nears, prompting investors to consider buying unlisted shares now or waiting for the public offering. Unlisted trading involves private negotiations and off-market transfers through specialized platforms before the exchange-based listing occurs.
In August, foreign investors channeled an impressive $3.1 billion into Indian equities, marking the largest monthly inflow in nearly two years. This surge in investment was bolstered by robust domestic earnings and proactive measures from the central bank. However, despite this positive trend, annual outflows are still trending towards a record high, with broader markets seeing an upswing even as major stocks faced declines.
The Indian rupee hit its highest level in almost four weeks against the US dollar, buoyed by fresh investments due to stock index adjustments and central bank actions. Closing the month in the green, the currency rebounded from previous losses. Additionally, foreign bank offers tied to MSCI index inflows offered support. Experts predict that the USD/INR pair may continue to weaken in the upcoming months.
Aurobindo Pharma shares rose sharply after its subsidiary Lannett Company launched the generic equivalent of Advair Diskus in the US. The inhalation product, available in two strengths, marks the first commercialised product from Aurobindo’s inhalation pipeline. The stock has gained 41.16% year-to-date in 2026.
HSBC has picked Titan Company and Kalyan Jewellers as its preferred jewellery stocks, citing growth opportunities from daily-wear jewellery and B2B manufacturing. The brokerage has retained Buy ratings on both stocks, with target prices of Rs 5,550 and Rs 770, respectively, while highlighting key risks including gold price volatility and competition.
China’s IPO market is gaining momentum, fuelled by strong investor appetite for AI, robotics and advanced technology companies. Hong Kong and Shanghai have already raised over $54 billion through IPOs and secondary listings in 2026, while blockbuster debuts such as CXMT and Unitree highlight the enthusiasm for tech stocks.
Systematix Research has initiated coverage of five affordable housing finance companies with Buy ratings, seeing 28-48% upside from current levels. The brokerage expects the sector to benefit from low mortgage penetration, rising incomes and urbanisation, with most covered companies projected to deliver loan growth in the low-to-mid-20% range through FY29.
Warning! Information Posting in this website is only for educational purpose. We are not responsible for losses incurred in Trading based on this information.